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ABSTRACT 
Oral Cancer in Nevada: A Public Health Perspective 
 
by 
 
Karl Kingsley, PhD 
 
Michelle Chino, Thesis Committee Chair 
Associate Professor, School of Community Health Sciences 
University of Nevada, Las Vegas 
 
Cancer is the second leading cause of death in the United States, and oral 
cancer remains the eighth leading cause of cancer death among US males.  Although 
previous epidemiologic studies have found that overall rates of cancer, including oral 
cancer, have declined in the US in recent decades – these declines are neither uniform 
nor consistent within this population.  Anecdotal evidence has suggested that rates of 
oral cancer in Nevada are relatively high, although no evidence was available to 
support these assertions. 
Oral Cancer Epidemiology: Based upon this information, a detailed and 
thorough epidemiologic examination of oral cancer rates in Nevada was undertaken.  
Chapter 1 describes a landmark publication in the journal BMC Public Health, which 
clearly demonstrated that oral cancer rates are, in fact, rising in specific geographic 
areas.  Moreover, the state with the highest documented sustained increases was 
Nevada.  In addition, although previous research has demonstrated increasing oral 
cancer rates among women and minorities, due to increased wealth, status and access 
over these past few decades – the observed increases in Nevada’s oral cancer rates 
were overwhelmingly within the white male population.   
Risk Factor Analysis: In a follow-up study to determine the factors responsible 
for the rising rates of oral cancer in Nevada, an in-depth analysis of the primary risk 
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factor for oral cancer development (tobacco usage) was performed.  Chapter 2 
outlines this study, submitted for publication in the journal Tobacco-Induced 
Diseases.  These results demonstrated that the increased incidence and mortality of 
oral cancer in Nevada was a state-specific phenomenon and not part of a larger, 
regional increase.  Moreover, trend analysis revealed that tobacco usage rates, 
although historically higher and linked to other factors, such as lower pricing, taxes 
and fewer workplace smoking bans, were recently found to be declining.  These 
findings are the first to provide evidence that suggests that rates of oral cancer within 
this specific geographic area may soon begin to decline. 
Environmental Factors: In addition to tobacco usage (smoking), many other 
risk factors may play a role in the development of oral cancers.  These additional risk 
factors include environmental factors, such as nutrition and diet, which are examined 
in Chapter 3.  For example, the recent adoption for required folate fortification in 
some food products, which has been shown to reduce negative health outcomes 
related to folate deficiency, has also been demonstrated to increase the rate of growth 
in undiagnosed (but pre-existing) colorectal cancers.  This raises the question of 
whether folate may play a similar and significant role in the accelerated growth of 
other slow developing cancers, such as oral cancers.  The timing of folate fortification 
in the US parallels the increased incidence of oral cancer in Nevada, suggesting that 
this environmental influence may also play an important role in the development and 
progression of this disease. 
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CHAPTER 1 
ANALYSIS OF ORAL CANCER EPIDEMIOLOGY IN THE US REVEALS 
STATE-SPECIFIC TRENDS: IMPLICATIONS FOR ORAL CANCER 
PREVENTION 
This chapter has been published in the peer-reviewed scientific journal BMC Public 
Health and is presented in the style of that journal.  The complete citation is: 
 
Kingsley  K, O’Malley S, Chino M.  Analysis of oral cancer epidemiology in the US 
reveals state-specific trends: implications for oral cancer prevention.  BMC Public 
Health 2008 8(1): 87. 
 
Abstract  
     Background: Downward trends have been observed in oral cancer incidence 
and mortality in the US over the past 30 years; however, these declines are not 
uniform within this population.  Several studies have now demonstrated an increase in 
the incidence and mortality from oral cancers among certain demographic groups, 
which may have resulted from increased risks or risk behaviors.  This study examines 
the underlying data that comprise these trends, to identify specific populations that 
may be at greater risk for morbidity and mortality from oral cancers. 
Methods: Oral cancer incidence and mortality data analyzed for this study 
were generated using the National Cancer Institute’s Surveillance, Epidemiology and 
End Results (SEER) program. 
Results: While oral cancer incidence and mortality rates have been declining 
over the past thirty years, these declines have reversed in the past five years among 
some demographic groups, including black females and white males.  Sorting of these 
data by state revealed that eight states exhibited increasing rates of oral cancer deaths, 
Nevada, North Carolina, Iowa, Ohio, Maine, Idaho, North Dakota, and Wyoming, in 
stark contrast to the national downward trend.  Furthermore, a detailed analysis of 
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data from these states revealed increasing rates of oral cancer among older white 
males, also contrary to the overall trends observed at the national level. 
Conclusions: These results signify that, despite the declining long-term trends 
in oral cancer incidence and mortality nationally, localized geographic areas exist 
where the incidence and mortality from oral cancers have been increasing.  These 
areas represent sites where public health education and prevention efforts may be 
focused to target these specific populations in an effort to improve health outcomes 
and reduce disparities within these populations. 
Roles of authors: 
Karl Kingsley, PhD 
MPH candidate 
Primary author 
Data generation 
Study design 
 
Susan O’Malley, MEd, MS 
Research Associate 
Secondary author 
Data analysis and manuscript editing 
 
Marcia Ditmyer, PhD 
Assistant Professor 
Secondary author 
Interpretation of data 
 
Michelle Chino, PhD 
Associate Professor 
Research Mentor 
MPH Committee Chair 
Background  
Although rates of oral cancer incidence and mortality in the US have declined 
over the past few decades, these declines have not been consistent or uniform within 
this population [1-4].  Collaborative reports using data from the National Cancer 
Institute (NCI), the Centers for Disease Control and Prevention (CDC) and the 
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American Cancer Society (ACS) have found increases in the incidence of oral cancer 
among specific segments of the population, including minorities [5-7]. While many 
advances in treatment and diagnosis have been made over the past three decades, oral 
cancer remains the eighth leading cause of cancer death among US males [8] and the 
five-year survival rate has remained low and relatively unchanged [9, 10].  Cancer 
remains the second leading cause of death in the US [11], and these observed 
increases in oral cancer provide compelling rationale for this study examining data 
underlying the general declining trends to elucidate which specific subsets of the 
population, as well as specific states or regions, that face increasing oral cancer rates. 
Recently, studies of oral cancer epidemiology demonstrated statistically 
significant differences in oral cancer rates among population subgroups, including 
minorities and various age groups, and between genders [12].  One such study 
demonstrated that although incidence rates of oral cancer have been steadily 
decreasing among white males, incidence rates among older black males (>65 years 
old) have been increasing [13].  In addition, this study demonstrated that oral cancer 
rates among females, in particular, have increased [13].  Although these data provide 
some evidence of the disparities in oral cancer rates between these populations, a 
more detailed examination may identify states, metropolitan areas or communities, as 
well as additional population sub-groups within these areas, which are experiencing 
increases in oral cancer incidence or mortality. 
This study will examine the underlying data that comprise the general trends, 
to identify specific populations within the US that may be at greater risk for morbidity 
and mortality from oral cancers. Epidemiology studies of oral cancer in Europe have 
found incidence and mortality rates have been declining steadily over the past few 
decades, similar to the trends found in the US, although more detailed analyses of the 
   4  
underlying data revealed that persistent upward trends were still present in a small 
subset of eastern European countries [14-18].  To perform a similar analysis for 
specific US states and counties, the NCI Surveillance, Epidemiology and End Results 
(SEER) website [19], a collaborative effort between the NCI and CDC, in conjunction 
with all US state registries, provides an interface for epidemiologists and other 
researchers to access and generate oral cancer statistics [20].  Due to the recently 
observed increases in oral cancer among particular segments of the US population, a 
more detailed analysis of the underlying data which comprise these general, long-term 
declining trends provides valuable information about significant short-term increases 
in specific geographic areas and among specific demographic groups. 
Methods 
Data sources: Population-based data for the US, specific to oral cancer, were 
obtained from the Surveillance, Epidemiology, and End Results (SEER) program.  
SEER provides cancer incidence and survival data from population-based cancer 
registries, representing approximately 25% of the US population [21].   All oral 
cancer statistics in this report are based on SEER incidence and National Center for 
Health Statistics (NCHS) mortality statistics, which consisted of cancers of the oral 
cavity and pharynx, including the lip, oral cavity and pharynx [22]. 
Incidence: Oral cancer incidence rates for each year between 1975 and 2004 
were obtained from SEER, age-adjusted to the year 2000 standard US population.  
The overall incidence trends for each time period (1975-2004; 1995-2004; 2000-
2004) were then calculated and subsequently graphed based on these data, dividing 
the most recent incidence rate by each specific earlier rate. 
Mortality: Oral cancer mortality rates for each year between 1975 and 2004, 
age-adjusted to the year 2000 standard US population, were also obtained from SEER.  
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Data qualified for inclusion in SEER as oral cavity and pharyngeal cancer if the 
underlying cause of death was specific for oral cancers [20].  The overall mortality 
trends over time for each time period (1975-2004; 1995-2004; 2000-2004) were 
calculated and graphed based on data from 1975-2004, dividing the most recent 
mortality rate by earlier rates. 
Annual percent change (APC) 1999-2003:Recent trend data in death rates 
from oral cancer from individual US states were calculated from the State Cancer 
Registries in SEER using the Joinpoint Regression Progression and are expressed as 
the APC over the reported trend period (1999-2003).  Current annual death rates of 
oral cancers from individual US states were similarly obtained and the most recent 
data available (2003, 2004) at the time of article preparation were reported.  Data 
were exported to Microsoft Excel, sorted in ascending order and graphed.   
US state data: Historical mortality data for cancers of the oral cavity and 
pharynx from selected US states, including Nevada, Idaho, North Dakota, and North 
Carolina, were calculated by NCI SEER*Stat, from data provided by the National 
Vital Statistics System public use data file.  Trends are based upon analysis calculated 
using the Joinpoint Regression Program statistical software program, which models 
the natural logarithm of the rates, identifying years at which any given trend changes, 
connecting these years graphically by a series of straight line segments [23, 24]. 
Results  
Age-adjusted incidence and mortality rates: Age-Adjusted Incidence Rates 
(AAIR) and Age-Adjusted Mortality Rates (AAMR) were generated and sorted by 
race and gender to gather more detailed information regarding oral cancer trends (Fig. 
1).  The oral cancer incidence and mortality trends were then further delineated into 
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three, distinct time periods, 1975-2004 (30 year), 1995-2004 (10 year) and 2000-2004 
(5 year), to allow for greater specificity within the overall temporal trend analysis.   
Age-adjusted incidence rates (AAIR): Analysis of the AAIR data revealed an 
overall declining trend in oral cancer incidence over the past 30 years (Fig. 1A).  
More specifically, over the past 30 years, oral cancer incidence has declined among 
white males (-1.21%), white females (-0.66%), black males (-1.53%) and black 
females (-1.38%), although these observed declines have not been uniform across 
time or demographic groups.  For example, although the incidence of oral cancer 
among black males has declined over the past 30 years, the temporal stratification of 
these data revealed that this decline was greatest over the past five years (-6.64%).  
Furthermore, this stratification also revealed a contrasting trend; the incidence of oral 
cancer among black females rose from -1.38%, over the entire 30 year period, to 
+3.18% during the most recent five year period. 
Age-adjusted mortality rates (AAMR): Analysis of the AAMR data also 
revealed an overall declining trend in oral cancer mortality over the past 30 years 
(Fig. 1B).  Although overall mortality decreased over 30 years for all groups 
analyzed, white males (-2.16%), white females (-1.62%), black males (-1.92%) and 
black females (-1.71%), more specific temporal analysis of oral cancer mortality 
revealed at least two distinct trends.  First, the decreases in mortality were greatest 
over the last 10 year period compared to the last 30 years and much less pronounced 
over the more recent five year period.  This trend was observed for white females, 
black males, and black females, but not white males.  The second trend, found only 
among white males, revealed that mortality, although still declining, was declining by 
ever smaller amounts over each time period: 30 years (-2.16%), 10 years (-1.83%), 
and  five years (-0.33%). 
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Geographic distribution: To determine if the temporal shifts observed in oral 
cancer incidence and mortality were associated with specific geographic regions or 
states, AAIR and AAMR were generated for all US states (Fig. 2).  AAIR and AAMR 
data were then further delineated into quantile intervals to highlight the rates for each 
state relative to the US averages, from highest (red) to lowest (dark blue). 
AAIR geographic distribution: Analysis of the AAIR geographic distribution 
data identified seven states in the highest quantile (11.7 to 13.7 cases per 100,000), 
the District of Columbia (13.7), Oklahoma (12.7), Louisiana (12.7), Georgia (12.6), 
Florida (12.5), Maine (12.2) and New Hampshire (11.8) (Fig. 2A).  Seven additional 
states were identified within the second highest quantile (11.0 to 11.6), Maryland 
(11.6), Alabama (11.5), Wisconsin (11.5), Missouri (11.4), Kentucky (11.4), Nevada 
(11.2) and Massachusetts (11.0).  All states within the two highest quantiles were 
located in the Eastern and Central zones, with the exception of Nevada (Pacific). 
AAMR geographic distribution: Analysis of the AAMR geographic 
distribution data revealed seven states within the highest quantile (3.3 to 4.4 deaths 
per 100,000), the District of Columbia (4.4), Arkansas (3.5), South Carolina (3.5), 
Louisiana (3.4), Alabama (3.3), Maine (3.3) and Nevada (3.3) (Fig. 2B).  The second 
highest quantile was comprised of four states, New Hampshire (3.2), Wyoming (3.2), 
Mississippi (3.0) and Tennessee (3.0).  Once again, the majority of states within the 
two highest quantiles were located in the Eastern and Central zones of the US, with 
the exception of Nevada (Pacific) and Wyoming (Mountain). 
Annual percent change in US states: The graphic organization of specific 
states with the highest levels of oral cancer incidence and mortality provides 
significant information regarding the geographic regions which are associated with 
these highest levels.  This information does not, however, delineate the areas which 
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have high levels of oral cancer incidence and mortality that are slowly decreasing 
over time and those that are increasing.  To make this determination, the most recent 
five year interval was selected to provide a more detailed temporal and geographic 
breakdown of the states reporting oral cancer incidence or mortality within the two 
highest quantiles, to determine if the annual percent change (APC) was decreasing at 
a slower rate, or increasing over time (Table 1). 
APC in US states with elevated incidence: Analysis of APC from the stratified 
AAIR data identified 14 states that were in the highest quantiles for oral cancer 
incidence (Table 1).  Of these states, 12 were found to have negative APC, which 
indicates a continuing decreasing trend in oral cancer incidence over the most recent 
five-year interval, although most of these decreases were comparatively lower than 
observed over the longest time interval (30 years).  Two states which did not follow 
this trend, however, and that were found to have increasing APC, were Maine 
(+2.2%) and Nevada (+4.6%). 
APC in US states with elevated mortality: Analysis of APC from the stratified 
AAMR data identified 11 states that were in the highest quantiles for oral cancer 
mortality (Table 1).  Of these states, eight were found to have negative APC, which 
suggests a continuing decreasing trend in oral cancer mortality, although most of the 
decreases were also comparatively lower than observed over the longest time interval 
(30 years).  Three states, however, were found to have increasing APC, Maine 
(+2.2%), Nevada (+4.6%) and Wyoming (+0.1%). 
US states with positive APC: Although we identified states with positive APC, 
in the highest quantiles for both oral cancer incidence and mortality (Maine, Nevada), 
one additional state was found to have positive APC, which was only found among 
the states with elevated mortality.  To determine if other states had increasing APC, 
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but were not among the states with the highest overall levels of oral cancer incidence 
or mortality, we expanded this analysis to include data for all US states.  This analysis 
revealed that eight states had increasing APC in oral cancer mortality (Fig. 3).  These 
states were Nevada (+4.6%), North Carolina (+4.0%), Iowa (+3.5%), Ohio (+3.4%), 
Maine (+2.2%), Idaho (+1.0%), North Dakota (+0.5%) and Wyoming (+0.15), only 
three of which were among the states with either the highest oral cancer incidence or 
mortality. 
Having identified eight states with recent increasing or positive trends (APC), 
a more detailed analysis of each of these states was performed to further examine 
these trends within each state.  The more detailed analysis of each state, year-to-year, 
spanning a 25 year period revealed significant, increasing trends in only four of these 
states, Nevada (Fig. 4), Idaho (Fig. 5), North Dakota (Fig. 6) and North Carolina (Fig. 
7). 
Nevada: Oral cancer mortality data for Nevada, the state with the highest five-
year APC (+4.6%), were stratified by race and gender (Fig. 4).  The analysis revealed 
that although the rates of oral cancer were decreasing for many years (1980-1997), a 
distinct upward trend was noted (1998-2004).  Moreover, this trend was most closely 
associated with white males (Fig. 4A).  The data for white males were then further 
stratified by age, revealing that the recent upward trends in oral cancer mortality were 
almost exclusively associated with white males over 50, and especially with white 
males over 65 (Fig. 4B). 
Idaho: Oral cancer mortality data for Idaho, another state identified with a 
positive five-year APC (+1.0), were also sorted by both race and gender (Fig. 5).  The 
results from this stratification revealed that the rates of oral cancer in Idaho have been 
slowly increasing for many years (1980-2004).  More specifically, this trend was 
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associated almost exclusively with white males (Fig. 5A), with too few data points to 
support trend analysis for any other race or gender grouping.  Separating the data for 
white males by age revealed that this upward trend was associated with white males 
over 50, but not older than 65 (Fig. 5B). 
North Dakota: Oral cancer mortality data for North Dakota, a state with a 
small, positive five-year APC (+0.5%), were also sorted by race and gender (Fig. 6).  
The results from this analysis revealed that rates of oral cancer in North Dakota have 
been slowly increasing over many years (1980-2004) and the increases were also 
associated with white males (Fig. 6A).  After separating these data by age, the results 
did not find this trend was associated with any specific age group (Fig. 6B). 
North Carolina: Oral cancer mortality data for North Carolina, a state with a 
positive five-year APC (+4.5%), were also sorted by race and gender (Fig. 7).  The 
results from this analysis, however, revealed that the recent increasing trend in oral 
cancer mortality (2001-2004) was primarily associated with black males (Fig. 7A).  
After the data for black males were further stratified by age, the upward trend was 
most closely associated with black males over 50, but not older than 65 (Fig. 7B). 
Discussion  
Although cancer ranks as the second leading cause of death in the United 
States, after heart disease, and remains an important problem facing public health 
professionals, the overall rates of cancer deaths have been steadily declining over the 
past few decades [25].   While this declining trend is welcome news for the general 
population and health professionals, it does not accurately describe the details which 
underlie these trends in which rates for some types of cancer have decreased 
significantly, while rates of other cancers have displayed opposing, increasing trends 
[11].  For example, although rates of lung cancer have steadily declined for decades, 
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cancers of the liver and thyroid have increased over the same period [3, 11, 26].  In 
the same fashion, the overall declining rates observed for oral cancer may obfuscate 
the underlying data which suggest that while the rates are declining among whites, 
they may be simultaneously increasing among other ethnic or demographic groups, 
such as blacks and females [13, 27]. 
To accurately understand the changes in oral cancer incidence and mortality, it 
is important to examine not only the composite data which describe the general trends 
for the US population over many years, but also to scrutinize the primary core data 
which convey more detailed information.  For example, these core data may include 
shorter intervals and year-by-year trends, as well as demographic and geographic 
breakdowns.  Although previous reports have noted that oral cancer incidence and 
mortality rates are not uniform across demographic groups [13, 27], this report is 
among the first to describe that oral cancer rates may be increasing over the short 
term, and that these increases are restricted to a small subset of states and particular 
demographic groups. 
Previous studies have described an overall declining trend in oral cancer 
incidence and mortality with the understanding that these decreases were found 
primarily among whites, and were not offset by smaller increases among other 
demographic groups [20, 28].  This report, however, provides evidence of three 
distinct trends, not previously articulated.  First, although oral cancer incidence and 
mortality have declined over the past thirty years, with the most significant declines 
observed over the past ten years, a reversal of these trends has emerged from the 
short-term (over the past five years) trend analysis, which may signify an important 
development in the epidemiology of this cancer.  Next, this report provides a 
geographic profile of oral cancer rates over time, revealing that although oral cancer 
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rates are continuing to decline in most states, they are now in fact increasing in a 
small subset of states.  Finally, in-depth stratification of data from these specific states 
revealed that oral cancer rates are increasing almost exclusively among older white 
males in three of these states, in sharp contrast to the general national trends. 
The identification of differential oral cancer trends among specific geographic 
areas and demographic groups in the US could indicate a shift in the epidemiology of 
this cancer.  A recent large-scale study among European countries revealed similar 
temporal and geographic trends [18].  For example, although oral cancer incidence 
and mortality has steadily declined in Europe as a whole since the 1980s, more 
detailed analysis by geographic region (country) revealed that mortality was rising in 
a subset of eastern European countries, most notably in Bulgaria, Romania, Hungary, 
Slovakia and Slovenia [16, 17].  Based upon these observations, the study authors 
speculated that the temporal and geographic nature of these patterns was related to 
changes in exposure to the two major risk factors for oral cancer, alcohol and tobacco.  
These items became more readily available and widely disseminated in these areas 
following the disintegration and break-up of the Soviet Union [18].   
Perhaps the increasing oral cancer trends identified in this study, in specific 
states and among specific demographic groups, are related to identifiable trends in 
oral cancer risk factors and behaviors, such as increased tobacco use or alcohol 
consumption, as was found in eastern European countries.  The most recent 
Behavioral Risk Factor Surveillance System (BRFSS) data confirms that six of the 
eight states identified in this report with increasing trends in oral cancer mortality 
were also among the states with higher than average rates of current smokers, which 
include Ohio, Nevada, North Carolina, Wyoming, Iowa and Maine [29].  Moreover, 
these states were also among the states with higher than average rates of heavy 
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alcohol consumers, with the exception of North Carolina.  Although these data 
suggest a correlation between alcohol and tobacco consumption patterns and oral 
cancer in these areas and among these demographic groups, the BRFSS data also 
provide some conflicting evidence, revealing that the states with the highest levels of 
current smokers and heavy alcohol consumers (Kentucky and Wisconsin, 
respectively) were not among those states with increasing rates of oral cancer 
incidence and mortality, but rather have decreasing rates, indicating that other risk 
factors may also be significant contributing factors. 
Although tobacco and alcohol consumption are the main risk factors for 
developing oral cancer, implicated in as many as 90 to 95% of head and neck cancers, 
other potential risk factors have recently emerged [30].  For instance, evidence for the 
role of infectious agents in the etiology of oral cancers has been mounting, 
demonstrating that oral infection with high-risk human papillomavirus (HPV) may not 
only increase the risk of developing oral cancer, but may also contribute to its 
progression [31, 32].  Other infectious agents and immune modulators, such as 
infection with the human immunodeficiency virus (HIV) and immune suppression, 
induced mainly via pharmacologic means to prevent rejection of transplanted organs, 
also significantly increase the risk of developing oral cancer [12].  In addition, recent 
evidence demonstrates that nutrition may play an important role in retarding the 
development and progression of oral cancers, revealing a nearly 50% reduction in oral 
cancer risk for each additional portion of fruits or vegetables consumed per day, even 
among tobacco and alcohol consumers [33-36].  Identifying those demographic 
groups and geographic areas experiencing increases in oral cancer will help direct 
public health research to understand how and why these rates may be increasing. 
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Conclusions  
It is imperative that further analysis of the contributing factors that underlie 
these temporal and geographic trends be undertaken.  This information may be 
indispensable to public health professionals as they strive to design population-
specific prevention and education programs, which are often funded and implemented 
at the local, regional and state levels.  Because many of the lifestyle behaviors which 
contribute to oral cancer risk are possible to impact through public health education 
and prevention strategies, more effective targeting of public health monies and efforts, 
towards the specific geographic regions and demographic populations which face 
these increased risks, may help to reverse these disturbing trends of increasing oral 
cancer, as outlined in this study. 
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 Figures 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 - Incidence and mortality trends for oral cancer in the US: Trends for the 
incidence (A) and mortality (B) rates of oral cancer cases reported to the SEER 
program from 1975-2004  in the US  were sorted by time period (30 year, 10 year and 
5 year), and by race/ethnicity and gender.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 - Geographic distribution of current incidence and mortality rates for oral 
cancer in the US: Age-adjusted incidence (A) and mortality (B) rates for all US states, 
for all races, all ages and both sexes, were ranked in quantiles, based upon cases per 
100,000 and mapped: created by statecancerprofiles.cancer.gov.  
Incidence Mortality
The APC is significantly different from zero (p<.05).*
3.1795-6.6394*-2.8021-0.00542000-2004
-0.4577-4.1620*-1.7163*-1.0551*1995-2004
-1.3792*-1.5273*-0.6589*-1.2058*1975-2004
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BlackWhite
-2.4798*-0.8092-1.8170*-0.33432000-2004
-4.4868*-3.5935*-2.2622*-1.8293*1995-2004
-1.7105*-1.9153*-1.6185*-2.1558*1975-2004
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The APC is significantly different from zero (p<.05).*A B
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Figure 3 - Annual percent change (APC) in mortality rates for oral cancer, 1999-2003: 
Annual Percent Change (APC) for the age-adjusted mortality rates for cancer of the 
oral cavity and pharynx, for all ages, genders and races, sorted by US state, 1999-
2003, were created by statecancerprofiles.cancer.gov, using NCI  SEER*Stat and 
sorted.  Eight states were identified with positive, increasing APC using this method.  
*N/Q: Data not provided because it did not meet United States Cancer Statistics 
(USCS) data quality standards for one or more years during the rate period of data 
collection.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 - Historical trends for oral cancer mortality in Nevada: Historical trends 
(1980-2004) of mortality from oral cancer were sorted by race/ethnicity and gender 
(A) using NCI SEER*Stat and regression lines calculated using the Joinpoint 
Regression Program.  Increasing trend in mortality among white males (1997-2004) 
was further delineated by age (B). 
 
US states (positive APC)  APC  Mortality Incidence  
Nevada    +4.6%  3.3/100,000 11.2/100,000 
North Carolina   +4.0  2.9  11.2 
Iowa     +3.5  2.4  11.0 
Ohio     +3.4  2.9  9.1 
Maine     +2.2  3.3  12.2 
Idaho     +1.0  2.3  10.6 
North Dakota   +0.5  2.1  9.4 
Wyoming    +0.1  3.2  N/Q* 
United States    -1.1%  2.6/100,000 10.4/100,000 
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Figure 5 - Historical trends for oral cancer mortality in Idaho: Historical trends (1980-
2004) of mortality from oral cancer were sorted by race/ethnicity and gender (A) 
using NCI SEER*Stat and regression lines calculated using the Joinpoint Regression 
Program.  Mortality among white males was sorted further by age (B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 - Historical trends for oral cancer mortality in North Dakota: Historical 
trends (1980-2004) of mortality from oral cancer were sorted by race/ethnicity and 
gender (A) using NCI SEER*Stat and regression lines calculated using the Joinpoint 
Regression Program.  Mortality among white males was then stratified by age (B). 
A B
A B
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Figure 7 - Historical trends for oral cancer mortality in North Carolina: Historical 
trends (1980-2004) of mortality from oral cancer were sorted by race/ethnicity and 
gender (A) using NCI SEER*Stat and regression lines calculated using the Joinpoint 
Regression Program.  The increasing trend among black males was sorted further by 
age (B). 
A B
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Tables 
Table 1 - Comparison of annual percent change (APC) in oral cancer mortality among 
US states with higher than average incidence and mortality: US states from the 
highest two quantiles of current oral cancer incidence and mortality were sorted in 
descending order to compare with recent (1999-2003) APC rate trends in mortality.  
Among these, three states were found to have increasing APC, Maine, Nevada, and 
Wyoming. 
US states  
(elevated incidence) 
APC trend 
(recent) 
Mortality rate 
(current) 
Incidence rate 
(current) 
District of Columbia -4.6% 4.4/100,000 13.7/100,000 
Oklahoma  -1.5 2.5 12.7 
Louisiana -1.2 3.4 12.7 
Georgia -2.8 2.9 12.6 
Florida -3.1 2.9 12.5 
Maine +2.2 3.3 12.2 
New Hampshire -0.9 3.2 11.8 
Maryland -2.9 2.5 11.6 
Alabama -1.2 3.3 11.5 
Wisconsin -1.5 2.6 11.5 
Kentucky -1.5 2.9 11.4 
Nevada +4.6 3.3 11.2 
Massachusetts -1.0 2.8 11.0 
United States -1.1% 2.6/100,000 10.4/100,000 
    
US states  
(elevated mortality) 
APC trend 
(recent) 
Mortality rate 
(current) 
Incidence rate 
(current) 
District of Columbia
  
-4.6% 4.4/100,000 13.7/100,000 
Arkansas 0.0 3.5 10.6 
South Carolina -3.7 3.5 10.1 
Louisiana -1.2 3.4 12.7 
Alabama -1.2 3.3 11.5 
Maine +2.2 3.3 12.2 
Nevada +4.6 3.3 11.2 
New Hampshire -0.9 3.2 11.8 
Wyoming +0.1 3.2 N/Q* 
Mississippi -0.1 3.0 N/Q* 
Tennessee -1.1 3.0 N/Q* 
United States -1.1% 2.6/100,000 10.4/100,000 
 
 *N/Q Data not provided because it did not meet United States Cancer Statistics 
(USCS) data quality standards for one or more years during the rate period of data 
collection.  
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CHAPTER 2 
ANALYSIS OF PRIMARY RISK FACTORS FOR ORAL CANCER FROM 
SELECT US STATES WITH INCREASING RATES 
This chapter has been accepted for publication in the peer-reviewed scientific journal 
Tobacco Induced Diseases and is presented in the style of that journal.  The complete 
citation is: 
 
Bunnell, A, Pettit N, Reddout N, Sharma K, O’Malley S, Chino M,  Kingsley K.  
Analysis of primary risk factors for oral cancer from select US states with increasing 
rates. Tobacco Induced Diseases 2010 In Press. 
 
Abstract 
Objectives: To examine the primary risk factor for oral cancer in the US, 
smoking and tobacco use, among the specific US states that experienced short-term 
increases in oral cancer incidence and mortality. 
Methods: Population-based data on oral cancer morbidity and mortality in the 
US were obtained from the National Cancer Institute’s (NCI) Surveillance, 
Epidemiology, and End Results (SEER) database for analysis of recent trends.  Data 
were also obtained from the Centers for Disease Control and Prevention (CDC) 
Behavioral Risk Factor Surveillance System (BRFSS) to measure current and former 
trends of tobacco usage.  To comprehensive measures of previous state tobacco use 
and tobacco-related policies, the Initial Outcomes Index (IOI, 1992-1993) and the 
Strength of Tobacco Control index (SoTC, 1999-2000) were also used for evaluation 
and comparison. 
Results: Analysis of the NCI-SEER data confirmed a previous report of 
geographic increases in oral cancer and demonstrated these were state-specific, were 
not regional, and were unrelated to previously observed increases among females and 
minorities.  Analysis of the CDC-BRFSS data revealed these states had relatively 
higher percentages of smokers currently, as well as historically.  In addition, analysis 
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of the IOI and SoTC indexes suggest that many factors, including cigarette pricing, 
taxes and home or workplace bans, may have had significant influence on smoking 
prevalence in these areas.  Trend analysis of these data uncovered a recent and 
significant reversal in smoking rates that suggest oral cancer incidence and mortality 
may also begin to decline in the near future. 
Conclusion: Due to the rising costs of health care in the US and the limited 
resources available for health prevention efforts, it is essential to organize and direct 
more effective efforts by public health officials and epidemiologists, as well as 
funding from local, state and federal governments, to reduce and eliminate identified 
health disparities.  This study provides evidence how these efforts may be directed to 
specific geographic areas, and towards the white males, previously thought to be 
unaffected by the increases in oral cancer among females and minorities. 
Roles of authors: 
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MPH candidate 
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Background 
Although oral cancer incidence and mortality rates have increased worldwide, 
these rates have been slowly and steadily declining among the US population over the 
past thirty years [1,2].  Despite the overall declining trends of oral cancer in the US, 
these declines are neither consistent nor uniform within this population [3,4].  
Researchers have found that the incidence among specific demographic subgroups 
may have actually increased over this same time period [5-7].  Recent studies have 
shown that rates of oral cancer have been steadily declining among males, but have 
risen sharply among females [8].  More specifically, the declining rates observed 
among males were specific mainly to white males, while increasing incidence was 
found among minorities, and black males, in particular [8].  A new study of oral 
cancer epidemiology has found that increases in incidence and mortality may also 
exhibit geographic specificity within the US [9], providing compelling rationale to 
analyze the risk factors for oral cancer within these specific geographic areas and 
among these specific demographic subgroups. 
Oral cancer incidence and mortality are correlated strongly with two major 
risk factors, tobacco use – consisting primarily of smoking in the US, and to a lesser 
extent, heavy alcohol use, which together account for the overwhelming majority of 
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cases [10].   A recent study of smoking and tobacco use in the US found that rates 
declined sharply among males between 1965 and 1990, while the rates among females 
and minorities had less pronounced declines, and in some instances, may have 
increased [11].  In fact, more recent studies provide strong evidence that increasing 
usage of non-traditional forms of tobacco in the US, such as cigars and water pipe 
smoking, have become increasingly popular among females and minorities [12].    
Although many studies have found correlations and linkages between increased 
workplace participation and social mobility, as well as acceptance and availability of 
tobacco products with the increasing rates of oral cancer among females and 
minorities, no studies to date have yet examined the relationship between increasing 
rates of oral cancer in a small subset of US states and the primary risk factors for oral 
cancer. 
A review of oral cancer epidemiology in Europe revealed morbidity and 
mortality have been steadily decreasing since the early 1980s, similar to the trends 
observed in the US [13].  Temporal and geographic patterns, however, have 
demonstrated increasing oral cancer rates among specific eastern European countries 
following the disintegration and dissolution of the Soviet Union [14,15].  These 
studies have demonstrated the increases were highly correlated to changes in exposure 
to the primary risk factors for oral cancer, including tobacco and alcohol, which 
became more readily available during this time [14,15].  Although no analogous 
geopolitical events have precipitated rapid, sharp increases in the availability of either 
tobacco or alcohol within these select US states with increasing oral cancer rates, 
significant differences in cigarette pricing and taxes, as well as specific laws 
regarding smoking bans, may have created state-specific environments that influence 
the prevalence of these oral cancer risk factors over time. 
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This study sought to examine the primary risk factors for oral cancer, focusing 
specifically on tobacco use and smoking prevalence, among the US states recently 
found to have increasing short-term oral cancer incidence and mortality rates, 
including Nevada, North Carolina, Iowa, Ohio, Maine, Idaho, North Dakota and 
Wyoming [9].  More specifically, the working hypothesis for this study was that state-
specific environmental factors may have led to increased tobacco use within these 
states.  Data from the National Cancer Institute (NCI) Surveillance, Epidemiology and 
End Results (SEER) database, and the Behavioral Risk Factor Surveillance System 
(BRFSS), supported by the Centers for Disease Control and Prevention (CDC), were 
used to access and generate oral cancer statistics and comparisons of risk factor 
prevalence in these specific US states, over time.  The identification of states, regions, 
or geographic areas with increased risk for oral cancer, as well as increased morbidity 
and mortality, is important because these represent sites where public health education 
and prevention efforts could be more effectively focused to improve health outcomes 
and reduce health disparities.   
Methods 
Mortality data: Surveillance, Epidemiology, and End Results (SEER): 
Population-based data on oral cancer in the US were obtained from the Surveillance, 
Epidemiology, and End Results (SEER) program.  SEER provides cancer incidence 
and survival data from population-based cancer registries, representing approximately 
25% of the US population [16].  All oral cancer statistics in this report are based on 
SEER incidence and National Center for Health Statistics (NCHS) mortality statistics, 
which consisted of cancers of the oral cavity, pharynx and lip [17].  Oral cancer 
mortality rates between 1975 and 2005 were also obtained from SEER for each year, 
age-adjusted to the year 2000 standard US population.  Deaths qualified for inclusion 
   28  
in SEER oral cavity and pharyngeal cancer if the underlying cause of death was 
specific for head and neck cancers [18].  The overall mortality trends over time were 
calculated and graphed based on available data from 1981-2005. 
Annual percent change (APC) for selected US states: Recent trend data in 
death rates from oral cancer in individual US states were calculated by the National 
Cancer Institute (NCI) SEER*Stat using data provided by the National Vital Statistics 
System public use data file (SEER) and from the State Cancer Registries using the 
Joinpoint Regression program and are expressed as the annual percent change (APC) 
over the reported trend period (1999-2003, for example) for selected US states.  These 
states included Nevada (NV), North Carolina (NC), Iowa (IA), Ohio (OH), Maine 
(ME), Idaho (ID), North Dakota (ND), Wyoming (WY), Arizona (AZ), California 
(CA), Oregon (OR) and Utah (UT).  Trends calculated using the Joinpoint Regression 
statistical software program model the natural logarithm of the rates, identifying years 
at which any given trend changes, connecting these years graphically by a series of 
straight line segments [19,20].  Current annual death rates of oral cancers from 
individual US states were similarly obtained and the most recent data available (2003, 
2004 or 2005) at the time of article preparation were reported.  
Risk factor data: Behavioral Risk Factor Surveillance System (BRFSS): 
Historical risk behavior data for tobacco use from selected US states were obtained 
from the Behavioral Risk Factor Surveillance System (BRFSS).  BRFSS is among the 
largest health surveillance and survey systems, responsible for tracking data monthly 
and reporting health conditions and risk behaviors from all US states, the District of 
Columbia, Puerto Rico, the U.S. Virgin Islands, and Guam, since 1984 [21].  BRFSS 
is part of the National Center for Chronic Disease Prevention and Health Promotion, 
sponsored by the Centers for Disease Control and Prevention (CDC). Data included 
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four level smoking status  (Smoke Every Day; Smoke Some Days; Former Smoker; 
Never Smoked), and adults who are current smokers.  Temporal data files were 
available for all states after 2001, and from selected states dating from 1984.   
Initial Outcomes Index (IOI) and Strength of Tobacco Control (SoTC): State-
specific data and rankings that form the US State Tobacco Control Initial Outcomes 
Index (IOI) were obtained from a previous report [22].  Measures used to generate the 
IOI index included smoking prevalence, computed as the percentage of current 
smokers who indicated at the time of the survey they smoked either every day or 
some days, per capita cigarette consumption, computed using total number of packs 
removed and sold in any given month divided by the US Bureau of Census estimates 
for state population aged 18 years or older at the time of the survey, weighted 
averages for cigarette prices during the time period analyzed, and the prevalence of 
workplace and home smoking bans.  For the index factors (cigarette price per pack, 
workplace smoking bans among ever smokers and home smoking bans among ever 
smokers) z scores were calculated and summed to form a tobacco control IOI, which 
was correlated with adult smoking prevalence and the point estimate of per capita 
cigarette consumption.   Similarly, state-specific data and rankings from 1999-2000 
form the standardized Strength of Tobacco Control (SoTC) index, which were also 
obtained from previous reports [23, 24].   Positive IOI or SoTC index scores indicate 
relatively robust state tobacco controls, including smoking bans, and generally reflect 
higher cigarette prices and taxes, while negative index scores indicate states with 
weaker tobacco controls, fewer smoking bans and comparatively lower cigarette 
prices and taxes.  
Results 
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Surveillance Epidemiology and End Results (SEER): Oral cancer rates in those 
selected states with previously identified increasing APC [9] were recalculated and 
updated to reveal any changes to the previous trends observed (Figure 1).  This re-
analysis confirmed the previous report that oral cancer rates have been decreasing in 
most US states, however a small subset of states have experienced recent increases in 
rates of death from oral cancer (Fig. 1B).  This data revision also confirmed the 
previous report that mortality in the state with the highest APC in oral cancer deaths, 
Nevada, was decreasing for many years (1981-1995) (Fig. 1A).  However, the distinct 
reversal and subsequent upward trend in deaths from oral cancer in Nevada was found 
to have begun earlier (1995-2005) than previously noted (1998-2004), providing 
further confirmation this upward trend appears not only to be continuing (2004-2005), 
but may also be increasing.  In addition, this analysis confirmed these observed 
increases were not among females or minorities, but instead were restricted primarily 
to white males. 
To determine if these trends were restricted to these particular states or if they 
are part of a larger regional increase, oral cancer rates for US states with contiguous 
geographic borders to Nevada were analyzed to determine any demonstrable changes 
(Fig 1B).  This analysis revealed the majority of states sharing a contiguous border 
with Nevada, including Arizona, California, Oregon and Utah, have all experienced 
decreasing rates of oral cancer deaths, similar to the national US trend. The only state 
bordering Nevada found to have a positive oral cancer APC was Idaho, a state 
previously identified as one of the subset of US states with increasing rates of death 
from oral cancer [9]. 
Behavioral Risk Factor Surveillance System (BRFSS): Epidemiologic 
evidence has previously demonstrated oral cancer incidence and mortality rates are 
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correlated strongly with two major risk factors, tobacco use – consisting primarily of 
smoking, and to a lesser extent, heavy alcohol use [10].  To assess the potential 
relationship between tobacco use, the primary risk factor for oral cancer, and the 
subset of US states with increasing oral cancer rates, data regarding tobacco use and 
smoking prevalence in these states was obtained from the Behavioral Risk Factor 
Surveillance System (BRFSS).  Analysis of these data demonstrated that the majority 
(7/8) of those states with elevated oral cancer APC also had current smoking rates 
(2007, most current available data) at or above the national average (Table 1).  
Moreover, all of the states sharing a contiguous border with Nevada, mainly with 
decreasing rates of oral cancer, were found to have current smoking rates at or below 
the national average.   
Initial Outcomes Index (IOI): Although current smoking rates may indicate 
state-specific usage for tobacco based on price, availability or other social and 
economic factors, current oral cancer mortality rates are generally the result of 
previous smoking prevalence [10].  Recent public health efforts have focused on 
developing comprehensive, state-specific measures of previous tobacco use through 
development of a comprehensive index that measured and ranked all US states 
according to multiple factors, including per capita tobacco consumption, cigarette 
prices, as well as workplace and home smoking bans.  One such comprehensive index 
or measure of previous smoking prevalence and tobacco control, known as the initial 
outcomes index (IOI), ranked all US states for these various factors between 1992 and 
1993.  Analysis of the IOI index data revealed the majority of states with increasing 
oral cancer APC also earned IOI scores in the LOW or MODERATE categories (6/8), 
mainly the result of higher rates of smoking and lower rates of tobacco control, such 
as lower cigarette prices and fewer smoking bans (Table 1).  Conversely, all of the 
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states sharing a contiguous border with Nevada, mainly those with decreasing oral 
cancer rates, earned IOI scores of HIGH – suggesting these states had lower smoking 
rates and higher overall tobacco controls, including higher cigarette prices and more 
extensive smoking bans.   
Strength of Tobacco Control (SoTC): Another comprehensive measure of 
previous state tobacco usage, known as the strength of tobacco control (SoTC), was 
subsequently developed by public health officials to rank and compare all US states in 
1999 and 2000, similar to the IOI.  Once again, an analysis of the SoTC index data 
revealed the majority of states with increasing oral cancer APC earned negative SoTC 
scores, with Nevada scoring the lowest (-1.42), suggesting that tobacco control in 
these states remained comparatively weak and less than the national mean index 
(mean=0.0, STD=1.20) (Table 1).  In contrast, all of the states sharing a contiguous 
border with Nevada had positive SoTC index scores.  When combined in this manner, 
these data provide compelling evidence that the current smoking prevalence in states 
with elevated oral cancer rates may have long-standing, historical trends of tobacco 
use and control that may explain, in part, these anomalous state-specific increases in 
oral cancer. 
Although the rates of oral cancer incidence and mortality have declined over 
the past thirty years, a reversal of these trends has recently emerged during the short-
term, which may signify an important change in the epidemiology of this cancer.  The 
IOI, SoTC, as well as current smoking rates provide important information regarding 
the overall prevalence of tobacco use at specific time points, indicating potential 
geographic areas that may suffer from tobacco-induced diseases, including oral 
cancer.  A more detailed examination of the changes in short-term trends of tobacco 
usage rates or smoking prevalence within these states was necessary to explore these 
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potential interactions and effects.  Based upon this information, data from BRFSS 
regarding annual smoking prevalence for states with elevated oral cancer APC and 
states with a contiguous border to Nevada were assessed to reveal any significant 
changes (Figure 2). 
Detailed analysis of this data revealed that most states with elevated oral 
cancer APC were found to have increases in the prevalence of smoking during the 
initial, short-term time period examined (1995 – 2000) (Fig. 2A).  In addition, most 
states sharing a contiguous border with Nevada were found to have decreases in the 
prevalence of smoking over this same time period, with the notable exception of 
Idaho.  To evaluate how these short-term changes in smoking rates may have changed 
over time, BRFSS smoking prevalence data for all available years (1995-2007) from 
the individual state with the highest oral cancer APC, Nevada, were obtained and 
plotted to reveal any significant trends (Fig. 2B).  This analysis demonstrated that 
although smoking rates in Nevada were initially increasing between 1995 and 1999, 
these rates have begun a more recent year-by-year decline – although they remain 
above the national average. 
To determine any changes in smoking prevalence occurring in the states 
examined so far, BRFSS data for all available years (1995-2007) were obtained and 
short-term changes in smoking rates were evaluated to uncover any significant trends 
(Table 2).  This analysis revealed that all of the states identified with elevated oral 
cancer APC also experienced an increase in smoking trends during one or more of the 
first four time intervals examined (1995-2000, 1996-2001, 1997-2002, 1998-2003).  
Furthermore, all of the states sharing a contiguous border with Nevada experienced 
only decreasing rates of smoking during these same intervals, with the exception of 
Idaho (Table 2).  Moreover, these data revealed an important shift and reversal in 
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smoking trends among the states with elevated oral cancer APC during the 1999-2004 
interval.  This reversal signified a dramatic decrease for each of these states, which 
has continued during all subsequent intervals (2000-2005, 2001-2006, 2002-2007), 
albeit by differing percentages. 
To further examine the changes in smoking prevalence over time from those 
states with elevated oral cancer APC, BRFSS data for each year were collected and 
graphed (Figure 3).  The year-by-year plot of individual states with elevated oral 
cancer rates demonstrated that although some initial increases were observed in each 
state, most states developed a general, decreasing trend that became evident between 
1999 and 2001 (Fig. 3A).  Plotting the smoking prevalence trends from Table 2 to 
visualize the changes over five-year intervals revealed the dramatic shift from mainly 
positive trends, or increases in reported state-wide smoking during the first four time 
intervals to negative trends, or net decreases in smoking during all subsequent time 
intervals (Fig. 3B). 
A similar examination of changes in smoking rates over time was performed 
using BRFSS data from those states sharing a contiguous border with Nevada to 
reveal any significant changes in trends and for comparison with those states 
experiencing elevated oral cancer APC (Figure 4).  In detail, the year-by-year plot of 
smoking trends from these states revealed that most experienced year-by-year 
decreases for the vast majority of years examined, with the notable exception of 
Nevada itself (Fig. 4A). A plot of the changes in smoking trends for each time period 
from Table 2 revealed that all of these states experienced declining rates of smoking 
during all intervals examined (1995-2000, 1996-2001, 1997-2002, 1998-2003, 1999-
2004, 2000-2005, 2001-2006, 2002-2007), with the notable exceptions of Nevada and 
Idaho (Fig. 4B). 
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Discussion 
The overall rates of cancer incidence and mortality have declined within the 
US in recent decades, but are not uniform or consistent within this population [1-4].  
Although strong evidence has shown increased rates among minority groups and 
women during this same period [5-7], recent evidence has suggested rates are also 
increasing within particular US states, creating additional health disparities [13].   
This study re-examined those data and confirmed that oral cancer rates have increased 
within this small subset of US states.  Moreover, further analysis verified that these 
trends are not part of larger, regional increases in oral cancer nor are they linked with 
the previously observed increases among females and minorities, but instead represent 
state-specific phenomenon with geographic specificity.  
Oral cancer has been linked primarily to tobacco use and smoking [10], 
therefore, this study sought to analyze comprehensive state demographic and 
behavioral data necessary to reveal the current and historical trends of tobacco use 
and smoking in these specific states.  Although it was expected, and confirmed, that 
states with higher rates of oral cancer had comparatively higher rates of current, as 
well as former, smokers than other states, this study exposed more recent, short-term 
trends that suggest these smoking rates have more recently reversed and are now 
steadily decreasing over time.  Because oral cancer incidence and mortality are 
generally the result of previous smoking prevalence, this reversal may signify that 
oral cancer rates within this subset of US states will also begin to decline, although 
previous observations suggest a lag time of many years [6,7,10,11]. 
Although epidemiologic studies of demographic and behavioral characteristics 
provide invaluable methods for identifying subgroups with increased risk for oral 
cancer within larger populations, this study provides strong evidence of other 
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potential variables, including state-specific indexes of policies and pricing structures 
for tobacco, that may create “geographic pockets” of increased risk, even among the 
general population. In addition, the inclusion of workplace and home smoking bans as 
integral components of the IOI and SoTC indexes may suggest these data have the 
potential to provide more nuanced and comprehensive measures of state-specific 
smoking activity and risk than the more commonly reported measures of current adult 
smokers or per capita cigarette consumption.  However, despite recent increases in the 
number of workplace smoking bans passed in several of these states, the role of 
second-hand smoke in the work or home environment may represent additional 
factors that further complicate and exacerbate the effects of tobacco use within these 
areas [25,26]. 
Aside from the confounding effects of second-hand smoke, several additional 
limitations of this study should be noted.  For example, some of these states have seen 
dramatic shifts in population, including a rapid influx of both casino and construction 
workers in Nevada, which were coupled with an influx of retired and elderly seeking 
affordable housing in warmer climates [27].  Although the survey and sampling of 
populations through the CDC, BRFSS and SEER should account for these shifts in 
population demographics, the possibility remains that these shifts could have skewed 
the data sampling, which may have resulted in the inaccurate representation of current 
or former smokers in each state - thereby influencing the outcome of these analyses.   
 
In addition, other potential risk factors for oral cancer have also recently been 
identified and these underlying medical conditions may have some effects on the 
different rates observed.  For example, immune suppression and immune modulation 
due to infection with the human immunodeficiency virus (HIV), or by pharmacologic 
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means to prevent rejection of tissue , have increased in prevalence within the US 
during these same time periods, although their recognized influences on the 
development of oral cancers have been the subject of relatively fewer epidemiologic 
investigations [28,29].  Additional evidence that other infectious agents, such as 
human papillomavirus (HPV), may increase the risk of developing oral cancer and 
contribute to its progression has also been accumulating [30-33].  Because few data 
specific to oral HPV prevalence or infection rates are currently available [34], 
assessing the potential association with increasing rates of oral cancer has remained 
elusive. 
Finally, additional studies examining other modulating factors for oral cancer 
development have identified potential risk factors that may also influence overall 
rates, incidence, and mortality.  Some studies have demonstrated an inverse 
relationship between the consumption of fruits or vegetables and oral cancer risk, 
indicating that dose-dependent reductions in oral cancer risk are possible with each 
additional serving of fruits or vegetables consumed [35-38].  Moreover, recent 
epidemiologic evidence has demonstrated that serum and tissue folate levels, highly 
correlated with fruit and vegetable consumption, may be inhibited by tobacco or 
alcohol use - known primarily for their direct and indirect carcinogenic effects rather 
than their modulating effects on micronutrient absorption [39-41].  Although 
preliminary epidemiologic studies have found inconclusive, and seemingly 
contradictory, effects of folate status on oral cancer risk [42,43], no studies to date 
have directly examined the association between folate status and state-specific or 
demographic increases in oral cancers.   
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Conclusion 
Due to the rising costs of health care in the US and the limited resources 
available for health prevention efforts, it is essential to organize and direct more 
effective efforts by public health officials and epidemiologists, as well as funding 
from local, state and federal governments, to reduce and eliminate identified health 
disparities.  This study provides evidence of state-specific increases in oral cancer that 
are not associated with the increases previously observed among females and 
minorities, thereby providing new insights regarding potential methods to identify 
changes in relevant trends in geographic areas which may experience increases in 
tobacco-induced diseases in the future.  As state and local public health professionals 
strive to formulate effective prevention and education programs for their residents, 
understanding the relationships between cause and effect, as well as the primary or 
secondary factors that more accurately indicate the potential for increased risk, 
becomes more imperative.   
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Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 – Analysis of state-specific oral cancer mortality data: Historical trends 
(1981-2005) of mortality from oral cancer were sorted by race and ethnicity using 
NCI SEER*Stat (National Cancer Institute Surveillance Epidemiology and End 
Results) and regression lines calculated using the Joinpoint Regression Program.  A) 
Oral cancer deaths in Nevada were initially declining, but exhibited a distinct, 
sustained upward trend among white males beginning in 1995. B) US states 
previously identified with short-term increases in oral cancer rates were confirmed as 
NV, NC, IA, OH, ME, ID, ND and WY, while states sharing a contiguous border with 
Nevada generally experienced declining trends. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 – Analysis of smoking trends in specific US states: A) Analysis of the annual 
percent change (APC) or change in smoking trends (1995-2000) from states with 
elevated oral cancer rates demonstrated these states experienced positive, increasing 
rates of smoking prevalence, while states sharing a contiguous border with Nevada 
experienced simultaneous negative or declining rates of smoking, with the exception 
of Idaho.  B) Graphing the smoking prevalence in Nevada revealed a year-by-year 
increasing trend which peaked in 1999 and subsequently began a steady, sustained 
decline over successive years.   
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Figure 3 – Analysis of annual smoking prevalence data in states with elevated oral 
cancer APC: A) A plot of annual data regarding state smoking prevalence 
demonstrates some initial variability among varying states, following by a more 
general declining trend beginning between 1999 and 2001.  B) Graphing the trend or 
five-year annual percent change (APC) from these states revealed the more general 
trend of variability during the initial time periods (1995-2000 through 1998-2003), 
that was followed by more general declining trends in subsequent periods (1999-2004 
through 2002-2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 – Analysis of annual smoking prevalence data in states sharing a contiguous 
border with Nevada: A) A plot of annual data regarding state smoking prevalence 
demonstrates a general declining trend for all states during the entire period of 
available data, with the exception of Nevada, initially.  B) Graphing the trend or five-
year annual percent change (APC) from these states revealed the general declining 
trends in all periods (1995-2000 through 2002-2007), with the notable exceptions of 
Nevada and Idaho. 
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Tables 
Table 1. Comparison of smoking rates and tobacco control in selected US states  
_____________________________________________________________________ 
State  Current rate Comparison  IOI   SoTC 
                        (2007)             (relative to US)           (1992-1993)          (1999-2000) 
Elevated APC states:  
NV  21.5%  ABOVE  +0.25    -1.42 
NC  22.9  ABOVE  -4.46 (LOW)  -0.14 
IA  19.8  SAME   -1.18 (LOW)  +0.41 
OH  23.1  ABOVE  -2.81 (LOW)  -1.05 
ME  20.2  ABOVE  +1.28 (HIGH)  -1.24 
ID  19.1  BELOW  +1.33 (HIGH)  +0.13 
ND  20.9  ABOVE  -0.29    -0.93 
WY  22.1  ABOVE  -2.11 (LOW)  -0.92 
 
Contiguous border states (NV):  
NV  21.5%  ABOVE   +0.25    -1.42 
AZ  19.8  SAME   +2.99 (HIGH)  +4.03 
CA  14.3  BELOW  +4.62 (HIGH)  +3.73 
ID  19.1  BELOW  +1.33 (HIGH)  +0.13 
OR  16.9  BELOW  +2.70 (HIGH)  +0.90 
UT  11.7  BELOW  +4.01 (HIGH)  -0.29 
 
US average 19.8%  N/A   N/A   mean=0.0 
          STD=1.20 
 
Table legend: NV (Nevada), NC (North Carolina), IA (Iowa), OH (Ohio), ME 
(Maine), ID (Idaho), ND (North Dakota), WY (Wyoming), AZ (Arizona), CA 
(California), OR (Oregon), UT (Utah). 
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Table 2. Comparison of smoking trends in selected US states  
_____________________________________________________________________ 
State  1995-2000 1997-2002  1999-2004 2001-200 
   1996-2001 1998-2003  2000-2005 2002-2007 
Elevated APC states:  
NV   +9.8 -4.6  -7.1 -16.8  -26.3 -20.3 -17.4 -17.3  
NC   +0.7  0.0 +1.9  +0.8    -7.9 -13.4 -14.0 -12.9 
IA     0.0 -6.3 +0.4   -7.2  -11.4 -12.1   -3.1 -14.6 
OH   +0.3 -2.8 +5.9   -3.4    -6.1 -14.9 -18.8 -13.1 
ME    -0.4 -5.5 +3.9  +5.8    -9.8 -12.6 -12.5 -14.5 
ID  +12.6 -7.1 +3.5   -6.4  -19.1 -19.7 -14.2   -7.2 
ND   +2.2 -5.5 -3.5  +2.5    -9.9 -13.4 -11.7   -2.7 
WY   +8.1 -9.7 -1.2  +7.8    -9.2 -10.5   -2.7   -6.7 
 
Contiguous border states (NV):  
NV    +9.8   -4.6   -7.1 -16.8  -26.3 -20.3 -17.4 -17.3  
AZ   -18.7   -9.2 -10.9   -4.5    -7.9   -8.6 -15.3 -15.3 
CA   -10.9   -7.5 -10.8 -12.5  -20.8 -11.6 -13.3 -12.8 
ID  +12.6   -7.1  +3.5   -6.4  -19.1 -19.7 -14.2   -7.2 
OR    -5.4 -12.3   -8.2   -0.9    -6.5 -10.6   -9.7 -24.5 
UT    -6.5      -4.3   -7.2 -16.1  -25.0 -10.8 -25.7   -8.5 
 
Table legend: NV (Nevada), NC (North Carolina), IA (Iowa), OH (Ohio), ME 
(Maine), ID (Idaho), ND (North Dakota), WY (Wyoming), AZ (Arizona), CA 
(California), OR (Oregon), UT (Utah). 
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CHAPTER 3 
POTENTIAL EFFECTS OF DIETARY FOLATE SUPPLEMENTATION ON 
ORAL CARCINOGENESIS, DEVELOPMENT AND PROGRESSION 
This chapter has been accepted for publication in the peer-reviewed scientific journal 
Journal of Dietary Supplements and is presented in the style of that journal.  The 
complete citation is: 
 
Kingsley K.  Potential effects of dietary folate supplementation on oral 
carcinogenesis, development and progression.  Journal of Dietary Supplements 
2010 In Press. 
 
Abstract 
 
Folates are associated with a variety of human health benefits, while folate deficiency 
has been identified as a potential risk factor for many health problems and cancers, 
due to its role in dysregulation of DNA synthesis, repair and methylation. The US 
Food and Drug Administration adopted requirements for folate fortification in some 
food products, which has resulted in an increase in mean dietary folate intake and a 
concomitant reduction in the incidence of adverse health effects associated with folate 
deficiency.  This includes a significant reduction in the incidence of folate deficiency-
associated birth defects, such as spina bifida.   
Although dietary folate supplementation protects normal, non-neoplastic cells 
from turning cancerous by preventing folate deficiency, more recent evidence 
suggests that folate supplementation may also contribute to some negative health 
effects.  For example, recent studies found that dietary folate supplementation resulted 
in the increasing rate at which some slow-developing, early-stage colon cancers 
proliferate.  The role of folate supplementation, and its effects on already developing 
colorectal cancers, now raises the question of whether folate might play a similar and 
significant role in the growth and proliferation of other slow-developing, early-stage 
cancers. 
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Another group of slow-developing cancers, oral cancer, may take many years 
or decades to develop and are often undetected and undiagnosed until later stages.  
However, no studies to date have adequately examined the potential ability of folate 
supplementation to alter the proliferative phenotype of established oral cancers, 
although growing epidemiologic evidence now suggests this may be a distinct 
possibility.  The relatively long time horizon for development of oral cancers provides 
an opportunity for folate supplementation to act as a potential modulator of oral tumor 
growth and development.   
In addition, many other factors are known to modulate cellular responses to 
micronutrients and dietary supplements, such as folate.  For example, high-risk human 
papillomavirus (HPV) infection has been proven to modulate proliferative phenotypes 
of many cancers to folate supplementation.  Recent studies of HPV infection in a 
significant fraction of oral cancers now confirm HPV alters growth and development 
within this subset of oral cancers.  These discoveries add further support that the 
relationships between HPV infection, folate supplementation and oral cancer growth 
should be thoroughly examined.  These data are critical and necessary components for 
understanding the impact of dietary folate supplementation and for directing more 
targeted and focused clinical and translational research in the prevention and 
treatment of oral cancers.    
Discussion 
Folic acid: Folates are associated with a variety of human health benefits, can 
be found in a wide assortment of foods, and are highly concentrated in certain dietary 
vegetables, grain products and some fruit juices [1].  Many important cellular 
functions involve folate-dependent processes, including amino acid metabolism and 
the formation of S-adenosylmethionine, the primary methyl donor for DNA 
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methylation reactions [2].  Folate deficiencies, resulting from low consumption of 
fruits and vegetables, strongly correlate with increased incidence of neural-tube 
defects, many cancers, hyperhomocysteinemia and vascular disease [3-5]. 
Folate deficiency: Folate deficiency has been identified as a potential risk 
factor for head and neck cancers, and oral cancers more specifically, due to its 
primary role in dysregulation of DNA synthesis, repair and DNA methylation 
associated with carcinogenesis [6].  The source of some folate deficiencies can be 
traced to a common DNA polymorphism in the methylenetetrahydrofolate reductase 
(MTHFR) gene, which encodes the enzyme responsible for producing the circulating 
form of folate [7, 8].  Other research has demonstrated that insufficient dietary folate 
intake, and poor diet in general, may be responsible for as much as 10-15% of all 
cases of oral cancer [9, 10].  In addition, other significant behavioral risk factors for 
oral cancer, such as tobacco and alcohol use, have been demonstrated to interfere with 
folate absorption, as well as increasing the rate of folate excretion by the kidney, 
thereby lowering folate concentrations in serum and tissues [11-13]. 
Folate supplementation: In an effort to reduce poor health outcomes 
associated with dietary folate deficiency, and to reduce incidence of neural tube 
defects, the US Food and Drug Administration (FDA) adopted requirements for folate 
fortification of all enriched cereal grain products beginning in 1996 [14].  USDA 
fortification guidelines specified each serving should contain at least 25% of the 
USDA recommended daily intake (RDI) of 400 micrograms per day (100 micrograms 
per serving). Nutrition scientists and epidemiologists, using data from the National 
Health and Nutritional Examination Survey (NHANES), demonstrated folate 
fortification and supplementation in the US has resulted in higher mean dietary folate 
intake, increasing from 275 to 351 micrograms per day.  This correlates with a 
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significant rise in folate concentrations measured in serum, as well as erythrocytes 
and tissues, increasing from 11.4 nmol/L to 26.9 nmol/L and 375 nmol/L to 590 
nmol/L, respectively [15].   The Centers for Disease Control and Prevention (CDC) 
attributes the 26% reduction in the incidence of neural tube defects in the US to these 
measures [16]. 
Folate toxicology: Although numerous health benefits are derived from 
mandatory folate supplementation, this policy can also create conditions of nutritional 
excess (hyperfolatemia) in some individuals, eliciting adverse clinical effects.  Folate 
concentrations within the normal physiologic range provide health benefits, however 
concentrations falling outside of this range, including deficiency (hypofolatemia) or 
excess (hyperfolatemia), can elicit strong adverse effects - the classic hormetic dose-
response relationship [17].  Inadvertent, but excessive, folate intake and higher folate 
serum levels above 400 micrograms per day are now known to clinically ‘mask’ 
megalobastic anemia, caused by vitamin B12 deficiency [18]. In addition, hyper 
supplementation of folate above these levels, extending to more than five milligrams 
per day, also causes neurologic damage in patients with undiagnosed pernicious 
anemia [19].  Recent studies and epidemiologic reviews now suggest that mandatory 
folic acid fortification may, in some cases, increase the risk of some cancers – due in 
part to this hormetic dose-response relationship but which may not be restricted to 
conditions involving hyper- and hypofolatemia [20, 21]. 
Folate and cancer: These seemingly contradictory findings may be explained 
by the dual roles of folate; the dose of folate supplementation determines the hormetic 
dose-response effects, while the timing of folate administration may influence a non-
hormetic response within the normal physiologic range.  While adequate folate status 
seems to protect normal, non-neoplastic cells from turning cancerous, normal levels 
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of folate also seem to increase the rate and speed at which cancerous cells grow.  
Conversely, folate depletion impairs existing cancers from growing, but can also 
simultaneously increase the risk of forming new cancers at other sites or tissues.  
Although treatment of folate deficiency with supplementation is an effective strategy 
to prevent oncogenesis, folate supplementation has an opposite effect on any existing 
or early-stage cancers or neoplasms [21, 22].  Cancers, by definition, are composed of 
rapidly dividing cells, thereby exhibiting an increased need for folate. Consequently 
anti-folate therapy has been used successfully to inhibit the growth of many tumors 
and metastatic cancers [23, 24].   
Oral cancer and folate: Oral carcinogenesis is a process that typically 
involves many separate, inter-related risks and corresponding mechanisms of 
transformation [25, 26].  This process may take many years or decades to become 
clinically apparent, thereby providing a window of opportunity for folate 
supplementation to modulate tumor growth and development.  Epidemiologic 
evidence has demonstrated the major risk factors for developing oral cancer are the 
use of tobacco and alcohol, known for their direct and indirect carcinogenic effects 
[27, 28].  However, these risk factors are also known for their ability to decrease 
serum and tissue folate levels [11-13].  Although some preliminary work and 
epidemiologic studies have found inconclusive, and seemingly contradictory, effects 
of MTHFR mutation and folate status on oral cancer risk, no studies to date have 
directly examined the effects of folate on existing or established oral cancers [8, 29].   
Folate and p53 expression: Most recently it has been shown that the effect of 
folate status differs significantly according to the p53 expression profile of the 
particular tumor [30].  Folate intake confers a protective effect against tumors that 
over-express p53, but has no effect on tumors that exhibit wild type p53 expression.   
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Interestingly, many of the earliest detectable events in oral carcinogenesis include 
disruptions to growth inhibitory or tumor suppression signals, most commonly 
involving proteins regulating the G1/S transition of the cell cycle – including p53, as 
well as Rb, bcl-2, and p16 [31-33].   
This intracellular dysregulation is facilitated in part by tobacco carcinogens, 
including polycyclic aromatic hydrocarbons (PAH) and nicotine-derived nitrosamines 
(NDN), which mediate oral carcinogenesis by activating DNA methyltransferases.  
These enzymes preferentially methylate CpG-rich DNA sequences found in exons 
248 and 273 of the p53 tumor suppressor gene, causing the transcriptional 
deregulation and subsequent mutation during DNA replication [34, 35].  p53 
deregulation then reduces the expression of other growth inhibitory regulators, such as 
p21 and bcl-2.  These regulators function to prevent the inactivation of the tumor 
suppressor Rb and to induce apoptosis [36, 37].  PAH and NDN also induce 
deregulation of p16, an inhibitor of cyclin CDKs, and p14/p29.  p14/p29 functions to 
inactivate mdm-2, which in turn down-regulates the p53 tumor suppressor [38], 
further complicating the potential effects and inter-relationships between folate 
supplementation and oral cancer development.  Based upon this information, the 
relationship between p53 expression, folate and oral carcinogenesis becomes clearly 
more complex than mere dysregulation of G1/S cell cycle mediators.   
Oral cancer and HPV: Although there is consensus among epidemiologists 
that most oral cancers originate from the deleterious effects of tobacco use and 
alcohol, recent evidence has demonstrated that human papillomavirus (HPV) infection 
is also a separate, independent risk factor for developing oral cancer [39, 40].  The 
human papillomaviruses are a family of dozens of related viruses that are involved in 
the development of warts and some cancers, more specifically cervical cancers [41].  
   52  
HPV oncoproteins disrupt the function of known tumor suppressor genes, leading to 
the production of transcription factors that ultimately drive cell proliferation, 
transformation and carcinogenesis [42-44].   
Recent evidence indicates the HPV types that cause cervical cancer are also 
found in a subset of oral cancers (30%) and are now thought to contribute to 
carcinogenesis in the oral cavity by mechanisms similar to those involved with the 
development of cervical cancers [39, 45, 46].   More specifically, the HPV 
oncoproteins, E6 and E7, produce ‘mdm-2-like’ proteins which bind to p53 and 
disrupt the tumor suppressor functions.  These oncoproteins also affect other 
associated tumor suppressors, including Rb and bcl-2, ultimately driving cell 
proliferation, transformation and carcinogenesis [47].    
HPV, folate and carcinogenic progression: Although great scientific emphasis 
has been placed upon HPV as the primary cause of cervical cancers and its 
involvement in carcinogenic progression of other cancers [41], less attention has been 
focused on the secondary factors that are associated with progression from subclinical 
HPV infection to invasive carcinoma.  Among the secondary factors that limit virus 
production and carcinogenic progression is CpG methylation of the HPV genome [48-
50].  Several studies now confirm that CpG site-specific methylation of HPV DNA, 
mediated in part by folate availability, is sufficient to suppress neoplastic progression 
[51-54].  In contrast, demethylation or hypomethylation of HPV-DNA sequences is 
required for transformation, revealing the importance of preferential DNA 
methylation at CpG sites in the HPV long control region (LCR) between L1 and E6 
HPV genes, in addition to the tumor suppressor sites in p53 exons 248 and 273 that 
were already discussed [55].  Because HPV has the potential to initiate oncogenesis, 
and also to modulate oral cancer growth and folate plays a central role in mediating 
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the availability of methyl groups for CpG-specific DNA methylation (modulating 
both p53 and HPV mRNA expression) – a thorough investigation of these inter-
connected and inter-related mechanisms in oral cancers must be undertaken. 
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Figure 1. Overview of selected environmental influences and genetic pathways in oral 
cancers that may be affected by folate supplementation.   
 
Summary 
The role of folate supplementation, and its effects on already developing 
colorectal and breast cancers, now raises the question of whether folate might play a 
similar and significant role in the growth and proliferation of already developing oral 
cancers.  To date, no studies have examined the potential ability of folate to alter the 
proliferative phenotype of established oral cancers, although growing epidemiologic 
evidence now suggests this may be a distinct possibility.  Moreover, the inter-
connected role of HPV infection, and its association with the growth and development 
of a subset of oral cancers, has not been explored with relation to folate 
supplementation or folate status. These data are critical and necessary components 
needed in order to establish clinical and translational research in this area.  The 
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ultimate goal is to provide new clinical treatments and diagnostic criteria for the 
approximately 45,000 new patients diagnosed with oral cancer in the US each year, 
who face a 40% five-year survival rate that has not changed significantly in many 
decades [56].   
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CHAPTER 4 
GENERAL DISCUSSION 
In this study, I sought to determine the temporal and geographic patterns of 
oral cancer morbidity and mortality within the US population.  Using well-established 
methods for epidemiologic research, I found a geographic and temporal pattern of 
increased oral cancer rates in a select subset of US states, including Nevada.  These 
published results demonstrate that oral cancer rates within specific geographic 
locations of the US have been, and are currently, increasing.  These results clearly 
demonstrated an important public health problem that exists within this state 
population.   
Based upon these results, I hypothesized that these observed increases were 
associated with state-specific exposures of this population to the primary risk factor 
for oral cancer development, tobacco use.  I attempted to analyze the use of tobacco 
within Nevada, as well as the neighboring states and found that rates of smoking and 
tobacco use were higher in this state than in neighboring states, as well as in 
comparison to national averages.  However, further research showed that these rates 
were also intricately linked to other factors that influence cigarette and tobacco 
consumption.  These included cigarette pricing and taxes, which were found to be 
significantly lower than in other regional states, such as Arizona, California and Utah.  
Moreover, the rates of smoking and tobacco use in Nevada, although historically 
higher than neighboring states have recently begun to decline.  This finding suggests 
that oral cancer rates may soon begin to decline within this population in the next ten 
to fifteen years, although significant input from public health officials will be required 
to avoid further health disparities. 
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The analysis of oral cancer primary risk factors provided the opportunity to 
consider additional, secondary factors that may also be environmental mediators of 
oral cancer risk.  Based upon research from the evidence base I found that specific 
nutritional and dietary changes within the US correlate strongly with the onset of the 
oral cancer increases observed in Nevada.  Specifically, the introduction of folate 
supplementation into the US food supply was strongly associated with the increased 
incidence and mortality from oral cancers in Nevada.  Furthermore, other studies have 
found that folate supplementation has increased the incidence and mortality from 
other slow growing cancers, such as colorectal cancer.  These discoveries are so 
recent that virtually no research has explored the possibility that folate 
supplementation may have influenced oral cancer rates in conjunction with other 
factors, such as higher rates of smoking due to state-specific taxing and policies.   
Recommendations 
Foster Interdisciplinary Research: Because cancer remains a leading cause of 
morbidity and mortality within the US and contributes substantially to the burden of 
rising healthcare costs, it is critical that biomedical research scientists become familiar 
with methods of public health investigation and epidemiologic research.  Moreover, it 
is important for public health professionals to collaborate with, and integrate, their 
efforts with biomedical research scientists.  This study incorporated the basic 
biomedical research focus of my laboratory, oral cancer growth and development, 
with the important elucidation of an increasing public health problem and health 
disparity in Nevada.   
Encourage Curricular Integration: It is my recommendation that public health 
professionals and educators incorporate these findings into health programs, curricula, 
and public service announcements in order to better serve the population of Nevada.  
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The School of Dental Medicine has found great success with integrating research into 
the basic science and biomedical curriculum for doctoral-level students and it is my 
hope that these established collaborative efforts will result in long-term collaboration 
and participation between the School of Community Health Sciences and the School 
of Dental Medicine. 
Mentoring: In addition, it is my recommendation that future students explore 
other aspects of oral cancer risk and epidemiology and to use this work as a 
foundation from which to explore other important aspects of public health efforts in 
this area.  For example, an on-going research focus of my laboratory research will be 
to explore the relationship between folate administration and supplementation with 
oral cancer growth and proliferation.  These studies can easily be linked with MPH 
research projects that examine these correlations within the patient population at the 
School of Dental Medicine, providing an additional avenue for interdisciplinary 
research and collaboration 
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